Explore
Trendline
Citi Upgrades Palantir's Earnings Forecast Amid Anticipated Commercial Growth
Citi Upgrades Palantir's Earnings Forecast Amid Anticipated Commercial Growth
Read More
Trendline
Figma Reports Significant Revenue Growth Amid Stock Price Decline
Figma Reports Significant Revenue Growth Amid Stock Price Decline
Read More
Trendline
Amkor Technology Expands Partnership with Nvidia, Forecasts Significant Revenue Growth
Amkor Technology Expands Partnership with Nvidia, Forecasts Significant Revenue Growth
Read More
Trendline
Taiwan Semiconductor Manufacturing Company Receives 'Buy' Consensus Rating Amid Strong AI Demand
Taiwan Semiconductor Manufacturing Company Receives 'Buy' Consensus Rating Amid Strong AI Demand
Read More
Trendline
Moderna's mRNA Cancer Program Sparks Valuation Debate Amid Stock Surge
Moderna's mRNA Cancer Program Sparks Valuation Debate Amid Stock Surge
Read More
Trendline
Medpace Holdings Reports Strong Q2 2026 Financial Results with Significant Revenue Growth
Medpace Holdings Reports Strong Q2 2026 Financial Results with Significant Revenue Growth
Read More
Trendline
Xeris Biopharma to Announce Q2 2026 Financial Results Amid Growth
Xeris Biopharma to Announce Q2 2026 Financial Results Amid Growth
Read More
Trendline
Xeris Biopharma to Release Second Quarter 2026 Financial Results and Host Conference Call
Xeris Biopharma to Release Second Quarter 2026 Financial Results and Host Conference Call
Read More
Trendline
Tesla's Q2 Earnings Fall Short Due to Increased R Costs Despite Revenue Growth
Tesla's Q2 Earnings Fall Short Due to Increased R Costs Despite Revenue Growth
Read More
Trendline
Xeris Biopharma to Announce Q2 2026 Financial Results in August
Xeris Biopharma to Announce Q2 2026 Financial Results in August
Read More
Trendline
Axiom Biosciences Plans Hong Kong IPO to Expand Clinical Trials
Axiom Biosciences Plans Hong Kong IPO to Expand Clinical Trials
Read More
Trendline
Verastem Oncology to Announce Q2 2026 Financial Results and Business Updates
Verastem Oncology to Announce Q2 2026 Financial Results and Business Updates
Read More
